Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

12 Oct 2007 07:00

Cyprotex PLC12 October 2007 Cyprotex PLC (the "Group" or "Cyprotex") NEWS 12 October 2007 Trading Update : Building Confidence The Director's confidence with Cyprotex's core operations continued to buildduring the third quarter of 2007. The Group enters the final three months ofits year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex'sfinancial year. Moreover, management is pleased to confirm that its customerbase has continued to expand rapidly. Included within the high number of newMSA (Master Services Agreements) recently signed, and taking the Group's 'activecustomer list' beyond 150 pharmaceutical and biotech companies, are severalinternational majors. Strict confidentiality agreements preclude Cyprotex fromnaming individual clients, but the company can now confirm it is currentlycontracted to work for six out of the world's 'top ten' global pharmaceuticalcompanies. The scale and visibility that strong working relationships with suchpartners are capable of providing, is key to proving Cyprotex's business plan.The management is pleased to report an exceptional level of repeat business,while also being asked to tenders for more long-term contract work as well asproject specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining asignificant, unused banking facility. Based on current momentum, managementsees the opportunity for modest cash generation to expand this 'cushion' stillfurther during the final three months of the 2007. For further information: Cyprotex PLCRobert Morrison Atwater, CEORussell Gibbs, CFOTel: +44 (0)1625 505 100ir@cyprotex.comwww.cyprotex.com Numura Code Securities LimitedCharles Walker, Corporate FinanceTel: +44 (0)20 7776 1200cew@nomuracode.comwww.nomuracode.com Media Enquires: WMC CommunicationsSimon MillerTel: +44 (0)20 7930 9030simon.miller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
27th May 20165:04 pmRNSReplacement Form 8.3 - Cyprotex PLC
27th May 20164:59 pmRNSReplacement Form 8.3 - Cyprotex PLC
27th May 20164:56 pmRNSReplacement Form 8.3 - Cyprotex Plc
27th May 20164:45 pmRNSForm 8.3 - Cyprotex Plc - Replacement
27th May 20163:28 pmRNSForm 8.3 - Cyprotex
27th May 20168:59 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
25th May 20161:49 pmRNSForm 8.3 - Cyprotex PLC
24th May 201610:56 amRNSForm 8.3 - Cyprotex PLC
24th May 20168:54 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
23rd May 20169:42 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
19th May 20162:38 pmRNSNotice of AGM
19th May 201610:59 amBUSForm 8.3 - Cyprotex Plc
17th May 20167:00 amRNSLaunch of New Enhanced Version of chemPK
16th May 201610:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th May 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
12th May 20169:37 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th May 20169:17 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th May 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
10th May 20167:00 amRNSTrading Update
9th May 201611:35 amRNSUpdate Re General Meeting
9th May 201610:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
4th May 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
3rd May 201610:35 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
29th Apr 201612:04 pmRNSForm 8.3 - Cyprotex
29th Apr 20169:38 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
28th Apr 20169:35 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
26th Apr 201611:24 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
26th Apr 20167:00 amRNSLaunch of GLP-Compliant Genotoxicity Services
25th Apr 201610:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
22nd Apr 20169:26 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
21st Apr 20164:53 pmRNSForm 8.3 - Cyprotex Plc
20th Apr 20164:37 pmRNSForm 8.3 - Cyprotex PLC
20th Apr 201610:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Apr 201611:40 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
15th Apr 201610:08 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Apr 201611:09 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
14th Apr 201610:10 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
13th Apr 201612:42 pmRNSReplacement Form 8.3 - Cyprotex plc
12th Apr 20161:57 pmRNSForm 8 (OPD) (Cyprotex PLC)
12th Apr 201612:18 pmRNSForm 8.3 - Cyprotex PLC
12th Apr 201611:18 amRNSForm 8.5 (EPT/RI)
12th Apr 201610:13 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Apr 20165:46 pmRNSRule 2.10 Announcement
11th Apr 20163:39 pmRNSForm 8.5 (EPT/RI) - Cyprotex Plc
11th Apr 201611:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
8th Apr 20164:32 pmRNSRule 2.10 Announcement
8th Apr 201612:07 pmRNSForm 8.5 (EPT/RI) - Cyprotex Plc- Amendment
8th Apr 201611:05 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
7th Apr 20164:35 pmPRNForm 8.3 - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.